Novel rhodesain inhibitors were obtained by combining an enantiomerically pure 3-bromoisoxazoline warhead with a specific peptidomimetic recognition moiety. All derivatives behaved as inhibitors of rhodesain, with low micromolar Ki values. Their activity against the enzyme was found to be paralleled by an in vitro antitrypanosomal activity, with IC50 values in the mid-micromolar range. Notably, a preference for parasitic over human proteases, specifically cathepsins B and L, was observed. Awakened by the warhead: Novel rhodesain inhibitors with antitrypanosomal activity were developed by coupling a 3-bromoisoxazoline warhead to a suitable peptidomimetic recognition moiety.

Development of Rhodesain Inhibitors with a 3-Bromoisoxazoline Warhead / R. Ettari, L. Tamborini, I.C. Angelo, S. Grasso, T. Schirmeister, L. Lo Presti, C. De Micheli, A. Pinto, P. Conti. - In: CHEMMEDCHEM. - ISSN 1860-7179. - 8:12(2013 Dec), pp. 2070-2076. [10.1002/cmdc.201300390]

Development of Rhodesain Inhibitors with a 3-Bromoisoxazoline Warhead

R. Ettari
Primo
;
L. Tamborini
Secondo
;
L. Lo Presti;C. De Micheli;A. Pinto
Penultimo
;
P. Conti
Ultimo
2013

Abstract

Novel rhodesain inhibitors were obtained by combining an enantiomerically pure 3-bromoisoxazoline warhead with a specific peptidomimetic recognition moiety. All derivatives behaved as inhibitors of rhodesain, with low micromolar Ki values. Their activity against the enzyme was found to be paralleled by an in vitro antitrypanosomal activity, with IC50 values in the mid-micromolar range. Notably, a preference for parasitic over human proteases, specifically cathepsins B and L, was observed. Awakened by the warhead: Novel rhodesain inhibitors with antitrypanosomal activity were developed by coupling a 3-bromoisoxazoline warhead to a suitable peptidomimetic recognition moiety.
inhibitors ; isoxazolines ; peptidomimetics ; rhodesain ; trypanosoma
Settore CHIM/08 - Chimica Farmaceutica
dic-2013
15-nov-2013
Article (author)
File in questo prodotto:
File Dimensione Formato  
ChemMedChem 2013.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 374.79 kB
Formato Adobe PDF
374.79 kB Adobe PDF [it] Default value:   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/228327
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 39
  • OpenAlex ND
social impact